Moderna's mRNA-1010 seasonal flu vaccine has received a unanimous green light from a federal advisory panel for adults 50 and older, signaling a potential breakthrough in flu prevention!
Get the details
#US #PublicHealth #CitizenPortal #FederalAdvisoryPanel #VaccineEfficacy #AgingPopulations
Get the details
#US #PublicHealth #CitizenPortal #FederalAdvisoryPanel #VaccineEfficacy #AgingPopulations
FDA advisory panel backs Moderna's mRNA seasonal influenza vaccine for adults 50 and older
At its June 18, 2026, VRBPAC meeting the committee voted 9–0 that Moderna’s mRNA‑1010’s benefits outweigh risks for adults 50–64 and 65+. FDA and the sponsor agreed on a post‑licensure randomized effectiveness study to compare mRNA‑1010 with enhanced vaccines in adults 65+.
citizenportal.ai
June 19, 2026 at 1:41 AM
Moderna's mRNA-1010 seasonal flu vaccine has received a unanimous green light from a federal advisory panel for adults 50 and older, signaling a potential breakthrough in flu prevention!
Get the details
#US #PublicHealth #CitizenPortal #FederalAdvisoryPanel #VaccineEfficacy #AgingPopulations
Get the details
#US #PublicHealth #CitizenPortal #FederalAdvisoryPanel #VaccineEfficacy #AgingPopulations